Allscripts Healthcare Solutions Inc. (MDRX) News
Filter MDRX News Items
MDRX News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
MDRX News Highlights
- For MDRX, its 30 day story count is now at 3.
- Over the past 5 days, the trend for MDRX's stories per day has been choppy and unclear. It has oscillated between 1 and 1.
- LEE are the most mentioned tickers in articles about MDRX.
Latest MDRX News From Around the Web
Below are the latest news stories about VERADIGM INC that investors may wish to consider to help them evaluate MDRX as an investment opportunity.
Veradigm Inc. Announces that Nasdaq Hearings Panel has Granted its Continued Listing, Pending Return to Compliance with Nasdaq Filing RequirementsCHICAGO, December 13, 2023--Veradigm Inc. (NASDAQ: MDRX (the "Company")) announced today that it received a decision from the Nasdaq Hearings Panel (the "Panel") granting its request for continued listing on the Nasdaq Capital Market, subject to the Company demonstrating compliance with Nasdaq Listing Rule 5250(c)(1) (the "Listing Rules") on or before February 27, 2024, and certain other conditions, including the achievement of various interim milestones (the "Panel Decision"). |
Veradigm to Enhance Independent Practice Financial Management with AI for Practice Fusion Billing ServicesCHICAGO, December 11, 2023--Veradigm Inc. (NASDAQ: MDRX), a leading provider of healthcare data and technology solutions, announced today that it will now offer a conversational artificial intelligence (AI) agent for Practice Fusion Billing Services, a Veradigm Network solution. Created to quickly answer questions in a conversational format designed to meet client needs, this enhancement will help simplify the billing process and optimize financial management for independent healthcare providers |
Veradigm Inc. Announces Leadership TransitionCHICAGO, December 08, 2023--Veradigm Inc. (Nasdaq: MDRX) announced today that the Company’s Board of Directors appointed current Chairman, Greg Garrison, as Executive Chairman, and current director, Dr. Shih-Yin ("Yin") Ho, as interim Chief Executive Officer. In addition, Lee Westerfield, who brings more than 25 years of experience as a senior financial executive, most recently serving as Chief Financial Officer at Clearsense, will be serving as Interim Chief Financial Officer. Chief Executive O |
Veradigm Inc. Receives Nasdaq Notice Regarding Delayed Form 10-QCHICAGO, November 17, 2023--Veradigm Inc. (Nasdaq: MDRX) announced today that, as expected, it received a notice from Nasdaq indicating that the Company remains noncompliant with Nasdaq Listing Rule 5250(c)(1) because the Company has not filed its Annual Report on Form 10-K for the year ended December 31, 2022 (the "Form 10-K"), Quarterly Report on Form 10-Q for the quarter ended March 31, 2023 (the "Q1 Form 10-Q"), Quarterly Report on Form 10-Q for the quarter ended June 30, 2023 (the "Q2 Form |
Returns At Veradigm (NASDAQ:MDRX) Are On The Way UpIf we want to find a stock that could multiply over the long term, what are the underlying trends we should look for... |
Veradigm to Simplify Patient Payment Journey with Veradigm Intelligent PaymentsCHICAGO, November 07, 2023--Veradigm, Inc. (NASDAQ: MDRX), a leading provider of healthcare data and technology solutions announced today that it will now offer a new solution to help increase payment rates, accelerate time to payment, and reduce manual reconciliation time for healthcare provider practices. Veradigm Intelligent Payments is a bundle of financial communications and payment solutions and is now available within Veradigm Payerpath via a collaboration with RevSpring, a leading and re |
Veradigm Inc. Announces Receipt of Nasdaq Stay ExtensionCHICAGO, October 09, 2023--Veradigm Inc. (NASDAQ: MDRX) announced today that, on October 6, 2023, it received a notice from Nasdaq indicating that the temporary stay of delisting of the Company’s common stock has been extended pending a hearing before the Nasdaq Hearings Panel (the "Panel") on November 16, 2023, and the issuance of a final Panel decision. |
Veradigm Joins FDB Vela ePrescribing Network to Offer Prescribers & Patients Greater Choice, Cost TransparencyFDB (First Databank, Inc.), a major provider of drug knowledge that helps healthcare professionals make precise decisions, and Veradigm (NASDAQ: MDRX), a well-known and respected provider of healthcare data and technology solutions, announced today that Veradigm is the first major electronic health record (EHR) network to join the FDB Vela™ ePrescribing network. Veradigm will integrate the FDB Vela ePrescribing network into its available solutions for users and partners, including its EHRs and t |
Holmusk, Veradigm Announce New Phase of Strategic Investment to Fuel Innovation and Close the Evidence Gap in Behavioral HealthCHICAGO & NEW YORK, October 02, 2023--Veradigm Inc. (NASDAQ: MDRX), a leading provider of healthcare data and technology solutions, and Holmusk, a leading global behavioral health real-world evidence company, today jointly announced the next stage in its strategic collaboration. |
Veradigm and On Belay Health Solutions Collaborate to Expand Value-Based Care Solutions to More Primary Care PracticesCHICAGO & BOSTON, September 28, 2023--Veradigm Inc. (NASDAQ: MDRX), a leading provider of healthcare data and technology solutions and On Belay Health Solutions, the company on a mission to empower primary care practices to succeed in value-based care, announced today a strategic collaboration to support primary care providers in improving patients’ health outcomes while strengthening their practices’ financial foundation. |